While Canopy Growth Corp CGC has announced strategic changes that could help lower its cost burden, the company is “sized for growth” that may not materialize in the medium-term, according to MKM Partners.
The Canopy Growth Analyst
Bill Kirk maintained a Neutral rating on Canopy Growth and reduced the price target from CA$21 ($15.56) to CA$19 ($14.08).
The Canopy Growth Thesis
Canopy Growth reported sequential deceleration in revenue and a wider EBITDA loss for the fiscal fourth quarter, while most peers announced sequential improvements, Kirk said in a Thursday note. (See his track record here.)
Canopy Growth identified certain strategic and organizational changes, like facilities closures, market exits and layoffs, which may reduce its cost burden, the analyst said.
Yet the company is too large for the current environment and continues to cultivate much more than it can sell, he said.
Kirk further said that Canopy Growth may not make much progress on the adjusted EBITDA front in fiscal 2021, given low-priced and lower -margin value offerings being the primary growth opportunity.
“Upside in Canopy shares is more likely via legislative changes/excitement than operational improvement.”
CGC Price Action
Shares of Canopy Growth had declined a little over 1% to $16.35 at the time of publication Thursday.
Related Links
Aphria, Aurora Analyst Says Buy The Dip To Take Advantage Of Cannabis Stock Sell-Off
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.